Tumor control probability model for alpha-particle-emitting radionuclides.
- 1 January 2000
- journal article
- Published by Radiation Research Society in Radiation Research
- Vol. 153 (1) , 16-22
- https://doi.org/10.1667/0033-7587(2000)153[0016:tcpmfa]2.0.co;2
Abstract
Alpha-particle emitters are currently being evaluated for the treatment of metastatic disease. The dosimetry of alpha-particle emitters is a challenge, however, because the stochastic patterns of energy deposition within cellular targets must be taken into account. We propose a model for the tumor control probability of alpha-particle emitters which takes into account these stochastic effects. An expression for cell survival, which is a function of the microdosimetric single-event specific-energy distribution, is multiplied by the number of cells within the tumor cluster. Poisson statistics is used to model the probability of zero surviving cells within the cluster. Based on this analysis, a number of observations have been made: (1) The dose required to eradicate a tumor is nearly a linear function of the cell survival parameter z(0). (2) Cells with smaller nuclei will require more dose to achieve the same level of tumor control probability, relative to cells with larger nuclei, for an identical source-target configuration and cell sensitivity. (3) As the targeting of alpha-particle emitters becomes more specific, the dose required to achieve a given level of tumor control decreases. (4) Additional secondary effects include cell shape and the initial alpha-particle energy.Keywords
This publication has 22 references indexed in Scilit:
- Vascular Targeted Radioimmunotherapy with 213Bi—An α-Particle EmitterNuclear Medicine and Biology, 1998
- In vitro and in vivo studies on the development of the α-emitting radionuclide bismuth 212 for intraperitoneal use against microscopic ovarian carcinomaAmerican Journal of Obstetrics and Gynecology, 1997
- Tissue distribution and radiation dosimetry of astatine-211-labeled chimeric 81C6, an α-particle-emitting immunoconjugateNuclear Medicine and Biology, 1997
- Targeted therapy using alpha emittersPhysics in Medicine & Biology, 1996
- Use of chord lengths through the nucleus to simulate the survival of mammalian cells exposed to high LET alpha-radiationInternational Journal of Radiation Biology, 1996
- α-Particle Radiotherapy with 211At-Labeled Monodisperse Polymer Particles, 211At-Labeled IgG Proteins, and Free 211At in a Murine Intraperitoneal Tumor ModelGynecologic Oncology, 1995
- Analytic microdosimetry for radioimmunotherapeutic alpha emittersMedical Physics, 1992
- A Relationship between Microdosimetric Spectra and Cell Survival for High-LET IrradiationInternational Journal of Radiation Biology, 1991